When the timing is right: Antibiotic timing and infection after cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 4, 2012, Pages

  Koch, Colleen G ^a   Nowicki, Edward R ^a   Rajeswaran, Jeevanantham ^a   Gordon, Steven M ^a   Sabik III, Joseph F ^a   Blackstone, Eugene H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; VANCOMYCIN;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; FEMALE; HEART SURGERY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; STERNOTOMY; STERNUM WOUND INFECTION; TIME; WOUND INFECTION;

EID: 84866371739     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.01.087     Document Type: Article

References (30)

1. N.K. Shrestha, M.K. Banbury, M. Weber, R.E. Cwynar, C. Lober, and G.W. Procop Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery Ann Thorac Surg 81 2006 2183 2188
2. A.E. Duncan, A. Abd-Elsayed, A. Maheshwari, M. Xu, E. Soltesz, and C.G. Koch Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery Anesthesiology 112 2010 860 871
3. R Development Core Team. R: a language and environment for statistical computing. 2008. Available at: http://www.R-project.org.
4. D.B. Rubin Multiple imputation for non-response in surveys 1997 Wiley New York
5. B. Efron, and R.J. Tibshirani An introduction to the bootstrap 1998 Chapman and Hall/CRC New York
6. L. Breiman Bagging predictors Machine Learning 24 1996 123 140
7. E.H. Blackstone Breaking down barriers: helpful breakthrough statistical methods you need to understand better J Thorac Cardiovasc Surg 122 2001 430 439
8. D.W. Bratzler, and P.M. Houck Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project Clin Infect Dis 38 2004 1706 1715
9. R. Kitzes-Cohen, D. Farin, G. Piva, S. Ivry, R. Sharony, and R. Amar Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery Ther Drug Monit 22 2000 661 667
10. F.H. Edwards, R.M. Engelman, P. Houck, D.M. Shahian, and C.R. Bridges The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration Ann Thorac Surg 81 2006 397 404
11. J.P. Steinberg, B.I. Braun, W.C. Hellinger, L. Kusek, M.R. Bozikis, and A.J. Bush Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors Ann Surg 250 2009 10 16
12. W.P. Weber, W.R. Marti, M. Zwahlen, H. Misteli, R. Rosenthal, and S. Reck The timing of surgical antimicrobial prophylaxis Ann Surg 247 2008 918 926
13. K.W. Garey, T. Dao, H. Chen, P. Amrutkar, N. Kumar, and M. Reiter Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections J Antimicrob Chemother 58 2006 645 650
14. K.W. Garey, P. Amrutkar, T.K. Dao-Tran, C.P. Frost, H. Chen, and E.J. Essien Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery Pharmacotherapy 28 2008 699 706
15. C.S. Abboud, S.B. Wey, and V.T. Baltar Risk factors for mediastinitis after cardiac surgery Ann Thorac Surg 77 2004 676 683
16. V.G. Fowler Jr., S.M. O'Brien, L.H. Muhlbaier, G.R. Corey, T.B. Ferguson, and E.D. Peterson Clinical predictors of major infections after cardiac surgery Circulation 112 9 Suppl 2005 I358 I365
17. J.H. Braxton, C.A. Marrin, P.D. McGrath, J.R. Morton, M. Norotsky, and D.C. Charlesworth 10-year follow-up of patients with and without mediastinitis Semin Thorac Cardiovasc Surg 16 2004 70 76
18. I. Risnes, M. Abdelnoor, S.M. Almdahl, and J.L. Svennevig Mediastinitis after coronary artery bypass grafting: risk factors and long-term survival Ann Thorac Surg 89 2010 1502 1509
19. R.J. Baskett, C.E. MacDougall, and D.B. Ross Is mediastinitis a preventable complication? A 10-year review Ann Thorac Surg 67 1999 462 465
20. T.D. Crabtree, J.E. Codd, V.J. Fraser, M.S. Bailey, M.A. Olsen, and R.J. Damiano Jr. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center Semin Thorac Cardiovasc Surg 16 2004 53 61
21. M.A. Olsen, P. Lock-Buckley, D. Hopkins, L.B. Polish, T.M. Sundt, and V.J. Fraser The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different J Thorac Cardiovasc Surg 124 2002 136 145
22. L. Ridderstolpe, H. Gill, H. Granfeldt, H. Ahlfeldt, and H. Rutberg Superficial and deep sternal wound complications: incidence, risk factors and mortality Eur J Cardiothorac Surg 20 2001 1168 1175
23. R. De Paulis, S. de Notaris, R. Scaffa, S. Nardella, J. Zeitani, and C. Del Giudice The effect of bilateral internal thoracic artery harvesting on superficial and deep sternal infection: the role of skeletonization J Thorac Cardiovasc Surg 129 2005 536 543
24. T.L. Demmy, S.B. Park, G.A. Liebler, J.A. Burkholder, T.D. Maher, and D.H. Benckart Recent experience with major sternal wound complications Ann Thorac Surg 49 1990 458 462
25. G.H. Tang, M. Maganti, R.D. Weisel, and M.A. Borger Prevention and management of deep sternal wound infection Semin Thorac Cardiovasc Surg 16 2004 62 69
26. J.H. Braxton, C.A. Marrin, P.D. McGrath, C.S. Ross, J.R. Morton, and M. Norotsky Mediastinitis and long-term survival after coronary artery bypass graft surgery Ann Thorac Surg 70 2000 2004 2007
27. R.A. Forse, B. Karam, L.D. MacLean, and N.V. Christou Antibiotic prophylaxis for surgery in morbidly obese patients Surgery 106 1989 750 757
28. C.E. Edmiston, C. Krepel, H. Kelly, J. Larson, D. Andris, and C. Hennen Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels? Surgery 136 2004 738 747
29. Acker M, Argenziano M, Puskas J, Ferguson B, Gelijns A, Horvath K, et al. Infections after cardiac surgery: initial experience from the Cardiothoracic Surgical Trials Network (abstract). Presented at: the 2011 American Heart Association annual meeting; November 12-16, 2011; Orlando, FL.
30. E.H. Blackstone, D.C. Naftel, and M.E. Turner Jr. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information J Am Stat Assoc 81 1986 615 624